Authors: Peter Sabo, Vahagn Makaryan, Yosef Dicken, Lital Povodovski, Liat Rockah, Tzlil Bar, Matan Gabay, Dalia Elinger, Ella Segal, Ora Haimov, Maya Antoshvili, Anat London Drori, Tanoya Poulsen, Asael Herman, Rafi Emmanuel, and David C. Dale
Emendo Biotherapeutics, today announced it will present an oral presentation and three posters relating to its next generation CRISPR-based gene editing approaches for several indications, at the 25th Annual Meeting of the American Society of Gene & Cell Therapy to be held May 16-19, 2022, in Washington, D.C.
Oral Presentation Details:
Title: A Novel Engineered CRISPR-Associated Nuclease Accurately Removes ELANE Mutated Allele and Shifts HSC Differentiation Towards Neutrophils in Severe Congenital Neutropenia
Session title: Gene Therapy for Immunologic Diseases
Session Date/Time: Tuesday May 17, 2022 3:45 PM – 5:30 PM
Presentation Time: 3:45pm – 4:00pm
Room: Room 202
Final abstract number: 482
Poster Presentations Details:
Title: A Unique CRISPR-Based Nuclease with a Non-NGG PAM Efficiently Targets Multiple Exclusive Genomic Sites for Immuno-Oncology Based Therapy
Session Title: Cancer – Targeted Gene and Cell Therapy I
Session Date/Time: Monday May 16, 2022 5:30 PM – 6:30 PM
Poster Board Number: M-215
Room: Hall D
Final abstract number: 334
Title: CRISPR-Based Gene Editing Enhances LDLR Expression and Boosts LDL-C Uptake in Familial Hypercholesterolemia
Session Title: Metabolic, Storage, Endocrine, Liver and Gastrointestinal Diseases II
Session Date/Time: Wednesday May 18, 2022 5:30 PM – 6:30 PM
Poster Board Number: W-125
Room: Hall D
Final abstract number: 999
Title: Challenges and Inconsistencies in Type II CRISPR-Associated Nuclease Subtype Classification
Session Title: Gene Targeting and Gene Correction II
Session Date/Time: Tuesday May 17, 2022 5:30 PM – 6:30 PM
Poster Board Number: Tu-61
Room: Hall D
Final abstract number: 556
Members of the Emendo Biotherapeutics R&D team will be on-site at the conference to present
the research in these sessions.
About the Annual Meeting of the American Society of Gene & Cell Therapy
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting, celebrating its 25th year in 2022, is the premier event for professionals in gene and cell therapy. The four-day meeting—and one preceding day of Pre-Meeting Workshops—is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers.
Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulatory agencies, equipment manufacturers, patient advocates, and more.
Emendo’s President & CEO, Dr. David Baram will be a keynote speaker in the upcoming BioMed conference in Tel-Aviv.